The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma

Merani, Shaheed; Majno, Pietro; Kneteman, Norman M; Berney, Thierry; Morel, Philippe; Mentha, Gilles; Toso, Christian

doi:10.1016/j.jhep.2010.12.040

Scientific article

Meta-analysis

English

The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma

ContributorsMerani, Shaheed; Majno, Pietro; Kneteman, Norman M; Berney, Thierry; Morel, Philippe; Mentha, Gilles; Toso, Christian

Published inJournal of hepatology, vol. 55, no. 4, p. 814-819

Publication date2011

Abstract

Liver transplantation is a recognized treatment for selected patients with hepatocellular carcinoma (HCC), but transplant criteria still need to be refined, especially in the case of more advanced or downstaged tumors.

Keywords

Biological Markers/blood
Carcinoma, Hepatocellular/blood/mortality/surgery
Female
Humans
Liver Neoplasms/blood/mortality/surgery
Liver Transplantation/mortality
Male
Middle Aged
Predictive Value of Tests
Registries/statistics & numerical data
Survival Rate
Treatment Outcome
Waiting Lists/mortality
Alpha-Fetoproteins/metabolism

Affiliation

Faculté de médecine / Section de médecine clinique / Département de chirurgie

Research group

Citation (ISO format)

MERANI, Shaheed et al. The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma. In: Journal of hepatology, 2011, vol. 55, n° 4, p. 814–819. doi: 10.1016/j.jhep.2010.12.040

Article (Published version)

Identifiers

PID : unige:24909
DOI : 10.1016/j.jhep.2010.12.040
PMID : 21334400

ISSN of the journal0168-8278

588views

1downloads

Creation11/08/2012 4:35:00 PM

First validation11/08/2012 4:35:00 PM

Update time03/14/2023 5:48:52 PM

Status update03/14/2023 5:48:52 PM

Last indexation10/18/2023 3:07:26 PM

Archive ouverte UNIGE

The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma

Liver transplantation is a recognized treatment for selected patients with hepatocellular carcinoma (HCC), but transplant criteria still need to be refined, especially in the case of more advanced or downstaged tumors.

Technical informations